Koelbl H - Search Results

1

Gene expression information improves reliability of receptor status in breast cancer patients.

Kenn M, Schlangen K, Castillo-Tong DC, Singer CF, Cibena M, Koelbl H, Schreiner W. Kenn M, et al. Among authors: koelbl h. Oncotarget. 2017 Aug 24;8(44):77341-77359. doi: 10.18632/oncotarget.20474. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100391 Free PMC article.

2

Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer.

Kenn M, Karch R, Cacsire Castillo-Tong D, Singer CF, Koelbl H, Schreiner W. Kenn M, et al. Among authors: koelbl h. J Pers Med. 2022 Apr 2;12(4):570. doi: 10.3390/jpm12040570. J Pers Med. 2022. PMID: 35455687 Free PMC article.

3

Decision theory for precision therapy of breast cancer.

Kenn M, Cacsire Castillo-Tong D, Singer CF, Karch R, Cibena M, Koelbl H, Schreiner W. Kenn M, et al. Among authors: koelbl h. Sci Rep. 2021 Feb 19;11(1):4233. doi: 10.1038/s41598-021-82418-7. Sci Rep. 2021. PMID: 33608588 Free PMC article.

4

Pembrolizumab Induces an Unexpected Conformational Change in the CC'-loop of PD-1.

Roither B, Oostenbrink C, Pfeiler G, Koelbl H, Schreiner W. Roither B, et al. Among authors: koelbl h. Cancers (Basel). 2020 Dec 22;13(1):5. doi: 10.3390/cancers13010005. Cancers (Basel). 2020. PMID: 33375020 Free PMC article.

5

Role of the progesterone receptor for paclitaxel resistance in primary breast cancer.

Schmidt M, Bremer E, Hasenclever D, Victor A, Gehrmann M, Steiner E, Schiffer IB, Gebhardt S, Lehr HA, Mahlke M, Hermes M, Mustea A, Tanner B, Koelbl H, Pilch H, Hengstler JG. Schmidt M, et al. Among authors: koelbl h. Br J Cancer. 2007 Jan 29;96(2):241-7. doi: 10.1038/sj.bjc.6603538. Epub 2007 Jan 9. Br J Cancer. 2007. PMID: 17211474 Free PMC article.

6

Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial.

Edlund K, Madjar K, Lebrecht A, Aktas B, Pilch H, Hoffmann G, Hofmann M, Kolberg HC, Boehm D, Battista M, Seehase M, Stewen K, Gebhard S, Cadenas C, Marchan R, Brenner W, Hasenburg A, Koelbl H, Solbach C, Gehrmann M, Tanner B, Weber KE, Loibl S, Sachinidis A, Rahnenführer J, Schmidt M, Hengstler JG. Edlund K, et al. Among authors: koelbl h. Clin Cancer Res. 2021 Apr 15;27(8):2148-2158. doi: 10.1158/1078-0432.CCR-20-2662. Epub 2021 Feb 4. Clin Cancer Res. 2021. PMID: 33542080 Clinical Trial.

7

Quantification of uPA receptor expression in human breast cancer cell lines by cRT-PCR.

Sliutz G, Eder H, Koelbl H, Tempfer C, Auerbach L, Schneeberger C, Kainz C, Zeillinger R. Sliutz G, et al. Among authors: koelbl h. Breast Cancer Res Treat. 1996;40(3):257-63. doi: 10.1007/BF01806814. Breast Cancer Res Treat. 1996. PMID: 8883968

8

The serum tumor marker M3/M21 in the follow-up of breast cancer patients.

Tempfer C, Hanzal E, Zeillinger R, Koelbl H, Dadak C, Kainz C. Tempfer C, et al. Among authors: koelbl h. Anticancer Res. 1996 Sep-Oct;16(5B):3049-52. Anticancer Res. 1996. PMID: 8920765

9

AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.

Seebacher V, Polterauer S, Reinthaller A, Koelbl H, Achleitner R, Berger A, Concin N. Seebacher V, et al. Among authors: koelbl h. BMC Cancer. 2018 Apr 19;18(1):447. doi: 10.1186/s12885-018-4289-6. BMC Cancer. 2018. PMID: 29673336 Free PMC article.

10

CA 125 in the follow-up of patients with ovarian cancer.

Koelbl H, Schieder K, Neunteufel W, Bieglmayer C. Koelbl H, et al. Eur J Obstet Gynecol Reprod Biol. 1988 Apr;27(4):335-42. doi: 10.1016/0028-2243(88)90047-0. Eur J Obstet Gynecol Reprod Biol. 1988. PMID: 3164284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page